Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glaxo Consumer Has Time To Spread Wings Before Potential Solo Flight

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline will not consider spinning off of its consumer health business for two to three years, when it can evaluate its "full value," says CEO Andrew Witty. Sales of the OTC intranasal corticosteroid Flonase Allergy Relief led the firm's US consumer business sales in the latest quarter and throughout 2015.

You may also be interested in...

Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight

Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.

Effusio Dissolvable, Eco-Friendly Nutrient Discs Launch Thorne In Functional Beverage Market

Thorne promotes Effusio dissolvable nutrient discs as a leg-up on competitors with highly absorbable ingredients delivered in a dissolvable disc without using plastic bottles. Launching with Probiotic + and Sleep +, the line will add an immune-boost formula later in 2021.

Prop 65 Warnings Intended For Small Spaces But Used On Luggage? California Proposes Limits

California proposes limiting short-form Prop 65 warnings to products with 5 inches or less of labeling space, while prohibiting their use in online and catalog warnings. The number of products with the warnings, used even on vacuum cleaners, luggage and guitars, has made tracking them impossible.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts